Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label study of RO7049389 with nucleos(t)ide analogs and pegylated interferon in chronic hepatitis B
CTR20192089Phase 2Active
- Sponsor
- Roche
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linvencorvir in Chronic Hepatitis B (CHB), sponsored by Roche. Started Apr 2020; status: active.
02
Drugs
linvencorvir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20192089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192089.